Summary by Moomoo AI
Biora Therapeutics, Inc. has filed a prospectus supplement on April 2, 2024, which updates and amends information from the original prospectus dated April 1, 2021. The supplement pertains to the offering of 349,650 shares of common stock, including shares issuable upon the exercise of warrants for 104,895 shares. The exercise price of these warrants has been amended multiple times, most recently adjusted to $1.10 per share following a reverse stock split that had previously increased the price to $8.22. The amendments, effective March 31, 2024, were made under a Warrant Amendment Agreement with an institutional investor. The agreement also stipulates that the warrants will not be exercisable until stockholder approval is obtained and extends the expiration date to five years post-approval. Biora Therapeutics' common stock is traded on the Nasdaq Global Market under the symbol 'BIOR,' with a last reported sale price of $1.10 per share as of March 28, 2024.